
This meta-analysis evaluates bleeding risks during percutaneous tracheostomy insertion in patients on antiplatelet and anticoagulation therapies. Analyzing 14 studies involving 3,485 procedures, no significant bleeding risk was found with single antiplatelet therapy (SAPT) or therapeutic anticoagulation (TAC). However, dual antiplatelet therapy (DAPT) showed a significantly increased bleeding risk (OR 2.05; 95% CI 1.18–3.56). Results suggest temporarily withholding DAPT or TAC, where clinically feasible, to minimize procedural bleeding risks.
Like
Save
Share